AI assistant
NEOGENOMICS INC — Director's Dealing 2020
May 27, 2020
32227_dirs_2020-05-27_27bccd6f-8ac0-48fc-a0a4-5f9b3d367448.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-05-25
Reporting Person: SHOVLIN ROBERT J. (President, Clinical Services)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-25 | Common Stock | F | 5405 | — | Disposed | 146235 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (66667.0) | 66667 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (96167.0) | 96167 | Direct |
| Stock Option (Right to Buy) | $19.6 | 2024-03-01 | Common Stock (66897.0) | 66897 | Direct |
| Stock Option (Right to Buy) | $28.33 | 2027-03-02 | Common Stock (56271.0) | 56271 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2020 vesting of restricted stock.
F2: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F3: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F5: On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.